PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 128 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,740 | -92.0% | 21,747 | -86.8% | 0.00% | -88.9% |
| Q2 2023 | $4,543,489 | -85.5% | 164,500 | -88.0% | 0.01% | -86.6% |
| Q1 2023 | $31,419,840 | +98.0% | 1,366,080 | -6.1% | 0.07% | +86.1% |
| Q4 2022 | $15,868,006 | +131.0% | 1,454,446 | +78.5% | 0.04% | +140.0% |
| Q3 2022 | $6,869,000 | +87.1% | 814,726 | +75.6% | 0.02% | +87.5% |
| Q2 2022 | $3,671,000 | +63.5% | 464,057 | +435.3% | 0.01% | -20.0% |
| Q1 2021 | $2,245,000 | -4.6% | 86,691 | -25.8% | 0.01% | -23.1% |
| Q4 2020 | $2,354,000 | +989.8% | 116,794 | +556.2% | 0.01% | +550.0% |
| Q2 2019 | $216,000 | – | 17,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $67,646,434 | 21.00% |
| COWEN AND COMPANY, LLC | 1,657,551 | $45,781,558 | 3.80% |
| Kynam Capital Management, LP | 975,298 | $26,937,731 | 3.70% |
| BVF INC/IL | 3,775,900 | $104,290,358 | 2.91% |
| RTW INVESTMENTS, LP | 5,415,514 | $149,576,497 | 2.85% |
| Cormorant Asset Management, LP | 1,500,000 | $41,430,000 | 2.32% |
| Ghost Tree Capital, LLC | 225,000 | $6,214,500 | 2.05% |
| 683 Capital Management, LLC | 814,000 | $22,482,680 | 1.62% |
| Perceptive Advisors | 1,469,761 | $40,594,799 | 1.18% |
| Artia Global Partners LP | 112,340 | $3,102,831 | 1.07% |